Haemonetics (HAE) Total Non-Current Liabilities (2010 - 2026)

Haemonetics has reported Total Non-Current Liabilities for 17 years, with the latest figure at $1.5 billion in Q1 2026.

• For the quarter ending Q1 2026, Total Non-Current Liabilities fell 1.39% year-over-year to $1.5 billion; the trailing twelve-month figure through Mar 2026 stood at $1.5 billion (down 1.39% YoY), and the FY2026 full-year result was $1.5 billion, down 1.39% from the prior year.
• Total Non-Current Liabilities for Q1 2026 stood at $1.5 billion, up from $1.5 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $1.6 billion in Q1 2025, with the low at $976.2 million in Q3 2022.
• Average Total Non-Current Liabilities over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
• Peak annual rise in Total Non-Current Liabilities reached 104.19% in 2022, while the deepest fall reached 4.29% in 2022.
• Tracing HAE's Total Non-Current Liabilities over 5 years: stood at $1.0 billion in 2022, then rose by 15.33% to $1.2 billion in 2023, then grew by 29.94% to $1.5 billion in 2024, then slipped by 1.21% to $1.5 billion in 2025, then advanced by 1.61% to $1.5 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $1.5 billion (Q1 2026), $1.5 billion (Q4 2025), and $1.5 billion (Q3 2025), per Business Quant data.

Peer Comparison